Open AccessTele-Dermatology in Clinical Management of Suspected Cutaneous Leishmaniasis in COVID-19 Pandemic
Author(s) -
Vikash Paudel
Publication year - 2020
Publication title -
nepal journal of dermatology, venereology and leprology
Language(s) - English
Resource type - Journals
eISSN - 2091-167X
pISSN - 2091-0231
DOI - 10.3126/njdvl.v18i1.31120
Subject(s) - teledermatology , pandemic , cutaneous leishmaniasis , covid-19 , dermatology , medicine , leishmaniasis , telemedicine , disease , pathology , infectious disease (medical specialty) , political science , health care , outbreak , law
The COVID-19 pandemic has changed the world dynamics in various prospects. It led to the restricted mobility of dermatological patients and helped telemedicine platform to flourish than ever. Though teledermatology has its own pros and cons, it’s being used in treatment of various skin disorders. Cutaneous leishmaniasis is an emerging disease in Nepal whose diagnosis is primarily clinical and histological. We are reporting a case of suspected cutaneous leishmaniasis from far western hilly region of Nepal who was empirically treated with fluconazole with the help of teledermatology platform with outstand outcomes.